Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,381,644
-
Share change
-
+6,051,921
-
Total reported value
-
$14,504,093
-
Price per share
-
$1.28
-
Number of holders
-
40
-
Value change
-
+$11,021,781
-
Number of buys
-
20
-
Number of sells
-
24
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q3 2023
As of 30 Sep 2023,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,381,644 shares.
The largest 10 holders included
Beryl Capital Management LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Yakira Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, CSS LLC/IL, DELTEC ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, Crystalline Management Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.